Tianda Pharmaceuticals Limited (HKG:0455)
0.0990
-0.0020 (-1.98%)
At close: Mar 10, 2026
Tianda Pharmaceuticals Balance Sheet
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 86.38 | 85.69 | 162.44 | 340.28 | 334 | 234.98 | Upgrade
|
| Short-Term Investments | 5.89 | 6.14 | 8.43 | 21.73 | 3.31 | 2.97 | Upgrade
|
| Trading Asset Securities | 6.04 | - | - | 3.17 | 14.58 | - | Upgrade
|
| Cash & Short-Term Investments | 98.3 | 91.83 | 170.87 | 365.17 | 351.9 | 237.96 | Upgrade
|
| Cash Growth | -5.27% | -46.26% | -53.21% | 3.77% | 47.88% | -24.05% | Upgrade
|
| Accounts Receivable | 58.41 | 77.42 | 104.8 | 138.75 | 141.74 | 145.21 | Upgrade
|
| Other Receivables | 2.09 | 3.97 | 1.57 | 4.07 | 3.15 | 2.93 | Upgrade
|
| Receivables | 60.5 | 81.39 | 106.38 | 142.82 | 144.89 | 148.14 | Upgrade
|
| Inventory | 51.78 | 40.21 | 65.15 | 48.19 | 74.89 | 64.39 | Upgrade
|
| Prepaid Expenses | 2.29 | 2.45 | 1.81 | 1.99 | 5.76 | 8.14 | Upgrade
|
| Other Current Assets | - | - | - | - | - | 147.77 | Upgrade
|
| Total Current Assets | 212.88 | 215.88 | 344.21 | 558.17 | 577.45 | 606.41 | Upgrade
|
| Property, Plant & Equipment | 392.77 | 386.09 | 412.74 | 400.51 | 433.09 | 377.78 | Upgrade
|
| Long-Term Investments | - | - | 9.22 | 0.74 | 1.77 | 6.87 | Upgrade
|
| Goodwill | 93.06 | 90.39 | 95.23 | 95.95 | 106.21 | 103.27 | Upgrade
|
| Other Intangible Assets | 62 | 27.21 | 1.31 | 1.75 | 15.51 | 19.56 | Upgrade
|
| Long-Term Deferred Charges | - | 33.32 | 19.36 | 4.37 | 6.43 | 8.23 | Upgrade
|
| Other Long-Term Assets | 14.1 | 12.14 | 35.22 | 26.97 | 23.7 | 11.35 | Upgrade
|
| Total Assets | 774.8 | 765.02 | 917.29 | 1,088 | 1,164 | 1,133 | Upgrade
|
| Accounts Payable | 97.86 | 77.82 | 117.99 | 80.73 | 110.11 | 91.54 | Upgrade
|
| Accrued Expenses | 32.12 | 29.37 | 64.31 | 71.19 | 63.99 | 59.9 | Upgrade
|
| Current Portion of Long-Term Debt | 80.63 | 122.07 | 96.49 | 64.67 | 57.26 | 18.89 | Upgrade
|
| Current Portion of Leases | 4.3 | 2.19 | 5.68 | 5.63 | 4.6 | 4.18 | Upgrade
|
| Current Income Taxes Payable | 0.43 | 0.75 | 3.74 | 3.72 | 4.24 | 3.73 | Upgrade
|
| Current Unearned Revenue | 9.88 | 8.43 | 13.71 | 111.73 | 14.08 | 11.76 | Upgrade
|
| Other Current Liabilities | 8.27 | 10.36 | 11.38 | 24.76 | 17.37 | 24.23 | Upgrade
|
| Total Current Liabilities | 233.49 | 251 | 313.31 | 362.43 | 271.66 | 214.23 | Upgrade
|
| Long-Term Debt | 44.28 | - | 8.36 | 61.97 | 90.63 | 110.8 | Upgrade
|
| Long-Term Leases | 6.35 | 3.18 | 3.07 | 8.77 | 7.94 | 11.65 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | 0.09 | 0.19 | 0.3 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 5.17 | 5.18 | 0.61 | 0.96 | 4.65 | 5.97 | Upgrade
|
| Total Liabilities | 289.3 | 259.36 | 325.35 | 434.23 | 375.08 | 342.97 | Upgrade
|
| Common Stock | 215 | 215 | 215 | 215 | 215 | 215 | Upgrade
|
| Additional Paid-In Capital | 359.07 | 359.07 | 364.66 | 364.66 | 364.66 | 364.66 | Upgrade
|
| Retained Earnings | 3.81 | 37.05 | 98.42 | 128.17 | 186.77 | 212.13 | Upgrade
|
| Comprehensive Income & Other | -91.95 | -105.29 | -86.02 | -80 | -9.68 | -35.09 | Upgrade
|
| Total Common Equity | 485.94 | 505.84 | 592.07 | 627.83 | 756.75 | 756.71 | Upgrade
|
| Minority Interest | -0.44 | -0.17 | -0.13 | 26.41 | 32.32 | 33.79 | Upgrade
|
| Shareholders' Equity | 485.5 | 505.67 | 591.94 | 654.24 | 789.08 | 790.49 | Upgrade
|
| Total Liabilities & Equity | 774.8 | 765.02 | 917.29 | 1,088 | 1,164 | 1,133 | Upgrade
|
| Total Debt | 135.56 | 127.45 | 113.6 | 141.05 | 160.43 | 145.53 | Upgrade
|
| Net Cash (Debt) | -37.26 | -35.61 | 57.28 | 224.12 | 191.47 | 92.43 | Upgrade
|
| Net Cash Growth | - | - | -74.44% | 17.06% | 107.15% | -67.92% | Upgrade
|
| Net Cash Per Share | -0.02 | -0.02 | 0.03 | 0.10 | 0.09 | 0.04 | Upgrade
|
| Filing Date Shares Outstanding | 2,150 | 2,150 | 2,150 | 2,150 | 2,150 | 2,150 | Upgrade
|
| Total Common Shares Outstanding | 2,150 | 2,150 | 2,150 | 2,150 | 2,150 | 2,150 | Upgrade
|
| Working Capital | -20.62 | -35.12 | 30.9 | 195.75 | 305.79 | 392.18 | Upgrade
|
| Book Value Per Share | 0.23 | 0.24 | 0.28 | 0.29 | 0.35 | 0.35 | Upgrade
|
| Tangible Book Value | 330.89 | 388.24 | 495.53 | 530.13 | 635.03 | 633.88 | Upgrade
|
| Tangible Book Value Per Share | 0.15 | 0.18 | 0.23 | 0.25 | 0.30 | 0.29 | Upgrade
|
| Buildings | - | 242.08 | 228.71 | 229.42 | 249.16 | 32.18 | Upgrade
|
| Machinery | - | 214.64 | 212.46 | 179.2 | 184.23 | 87.97 | Upgrade
|
| Construction In Progress | - | 25.34 | 40.39 | 28.98 | 23.69 | 267.05 | Upgrade
|
| Leasehold Improvements | - | 5.72 | 4.71 | 4.02 | 4.17 | 3.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.